Home082800 • KOSDAQ
add
Vivozon Pharmaceutical Co Ltd
Previous close
₩7,350.00
Year range
₩2,715.00 - ₩13,600.00
Market cap
368.27B KRW
Avg Volume
1.90M
P/E ratio
-
Dividend yield
-
Primary exchange
KOSDAQ
Market news
Investopedia
1 hour ago
S&P 500 Gains and Losses Today: Eli Lilly Stock Falls as Sales Outlook
Weakens
0.11%
Financials
Income Statement
Revenue
Net income
| (KRW) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 23.63B | 32.21% |
Operating expense | 11.26B | 81.33% |
Net income | 255.84M | -1.84% |
Net profit margin | 1.08 | -26.03% |
Earnings per share | — | — |
EBITDA | 2.22B | 0.27% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.85B | -3.10% |
Total assets | 175.73B | -1.58% |
Total liabilities | 70.63B | 1.46% |
Total equity | 105.10B | — |
Shares outstanding | 47.52M | — |
Price to book | 3.32 | — |
Return on assets | 1.86% | — |
Return on capital | 2.25% | — |
Cash Flow
Net change in cash
| (KRW) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 255.84M | -1.84% |
Cash from operations | 3.77B | 221.67% |
Cash from investing | -2.14B | -1,585.66% |
Cash from financing | 84.97M | 102.81% |
Net change in cash | 1.72B | 200.61% |
Free cash flow | 506.90M | 127.74% |
About
Founded
2002
Website
Employees
328
